Health
Researchers tie cold viruses used to deliver COVID-19 vaccine to rare blood clot risk – ABS-CBN News
German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among…
German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among some people who received COVID-19 vaccines made by AstraZeneca Plc and Johnson & Johnson.
The researchers, in a study not yet reviewed by experts, said COVID-19 vaccines that employ adenovirus vectors – cold viruses used to deliver vaccine material – send some of their payload into the nucleus of cells, where some of the instructions…
-
General22 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General24 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
General22 hours agoLithium mine closure shines light on Ravensthorpe community’s resilience
-
Noosa News21 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba